Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sustained-release vs normal-release aspirin in chronic coronary artery disease
2004-000398-76Phase 2Active
- Sponsor
- Madaus GmbH
- Start
- Jun 2004
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of Cartia and aspirin in coronary arteriosclerosis (2 arms), sponsored by Madaus GmbH. Primary endpoints: Platelet function parameters, Prostanoid synthesis parameters and 2 more. Started Jun 2004; status: active.
02
Drugs
Cartiaaspirin
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on 2004-000398-76.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-000398-76.